Shagun Singh
Stock Analyst at RBC Capital
(3.29)
# 1,045
Out of 4,981 analysts
226
Total ratings
53.65%
Success rate
0.16%
Average return
Main Sectors:
Stocks Rated by Shagun Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OM Outset Medical | Reiterates: Sector Perform | $22 | $13.74 | +60.12% | 13 | Aug 19, 2025 | |
| ISRG Intuitive Surgical | Reiterates: Outperform | $615 | $435.88 | +41.09% | 16 | Aug 19, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $112 → $115 | $101.18 | +13.66% | 16 | Aug 8, 2025 | |
| PODD Insulet | Maintains: Outperform | $330 → $350 | $342.24 | +2.27% | 2 | Aug 8, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Outperform | $45 → $25 | $12.13 | +106.10% | 3 | Aug 7, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $215 → $180 | $79.31 | +126.96% | 6 | Aug 5, 2025 | |
| TFX Teleflex | Maintains: Sector Perform | $130 → $135 | $124.94 | +8.05% | 22 | Aug 1, 2025 | |
| PEN Penumbra | Maintains: Outperform | $330 → $325 | $266.48 | +21.96% | 15 | Jul 30, 2025 | |
| EW Edwards Lifesciences | Maintains: Outperform | $85 → $89 | $76.62 | +16.16% | 22 | Jul 25, 2025 | |
| JNJ Johnson & Johnson | Maintains: Outperform | $181 → $185 | $177.45 | +4.25% | 22 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $4 → $3 | $1.50 | +100.00% | 8 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $145 → $147 | $131.77 | +11.56% | 16 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $105 → $101 | $93.52 | +8.00% | 21 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $116 → $120 | $100.90 | +18.93% | 16 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $425 → $435 | $379.69 | +14.57% | 19 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $92 | $58.34 | +57.70% | 5 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $115 | $75.64 | +52.04% | 4 | Oct 25, 2024 |
Outset Medical
Aug 19, 2025
Reiterates: Sector Perform
Price Target: $22
Current: $13.74
Upside: +60.12%
Intuitive Surgical
Aug 19, 2025
Reiterates: Outperform
Price Target: $615
Current: $435.88
Upside: +41.09%
Zimmer Biomet Holdings
Aug 8, 2025
Maintains: Outperform
Price Target: $112 → $115
Current: $101.18
Upside: +13.66%
Insulet
Aug 8, 2025
Maintains: Outperform
Price Target: $330 → $350
Current: $342.24
Upside: +2.27%
Tandem Diabetes Care
Aug 7, 2025
Maintains: Outperform
Price Target: $45 → $25
Current: $12.13
Upside: +106.10%
Inspire Medical Systems
Aug 5, 2025
Maintains: Outperform
Price Target: $215 → $180
Current: $79.31
Upside: +126.96%
Teleflex
Aug 1, 2025
Maintains: Sector Perform
Price Target: $130 → $135
Current: $124.94
Upside: +8.05%
Penumbra
Jul 30, 2025
Maintains: Outperform
Price Target: $330 → $325
Current: $266.48
Upside: +21.96%
Edwards Lifesciences
Jul 25, 2025
Maintains: Outperform
Price Target: $85 → $89
Current: $76.62
Upside: +16.16%
Johnson & Johnson
Jul 17, 2025
Maintains: Outperform
Price Target: $181 → $185
Current: $177.45
Upside: +4.25%
Jul 15, 2025
Maintains: Sector Perform
Price Target: $4 → $3
Current: $1.50
Upside: +100.00%
Jul 15, 2025
Maintains: Outperform
Price Target: $145 → $147
Current: $131.77
Upside: +11.56%
May 22, 2025
Maintains: Outperform
Price Target: $105 → $101
Current: $93.52
Upside: +8.00%
Apr 24, 2025
Maintains: Outperform
Price Target: $116 → $120
Current: $100.90
Upside: +18.93%
Jan 29, 2025
Maintains: Outperform
Price Target: $425 → $435
Current: $379.69
Upside: +14.57%
Nov 6, 2024
Maintains: Outperform
Price Target: $80 → $92
Current: $58.34
Upside: +57.70%
Oct 25, 2024
Maintains: Outperform
Price Target: $120 → $115
Current: $75.64
Upside: +52.04%